ACCESSION: MSBNK-SMB_Measured-HSA001P0212028
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 47
COMMENT: RAW_SPEC {'ProcedureBlank_4574': {'bp': 1271641.0, 'sum': 1947039.0}, '18_posi_5308': {'bp': 804883.0, 'sum': 1396503.0}, '16_posi_5184': {'bp': 899361.0, 'sum': 1508736.0}, '13_posi_5222': {'bp': 913614.0, 'sum': 1668948.0}, '11_posi_5287': {'bp': 946631.0, 'sum': 1783286.0}, '16_posi_5269': {'bp': 875112.0, 'sum': 1343418.0}, '17_posi_5118': {'bp': 859830.0, 'sum': 1649591.0}, '11_posi_5204': {'bp': 959806.0, 'sum': 1599792.0}, '3_posi_5143': {'bp': 970762.0, 'sum': 1577662.0}, '16_posi_5098': {'bp': 1064571.0, 'sum': 1826957.0}, '17_posi_5284': {'bp': 816373.0, 'sum': 1310599.0}, '1_posi_5138': {'bp': 1056582.0, 'sum': 1835981.0}, '13_posi_5144': {'bp': 1054405.0, 'sum': 1956048.0}, '1_posi_5220': {'bp': 1001993.0, 'sum': 1783140.0}, '12_posi_5266': {'bp': 843353.0, 'sum': 1404872.0}, '9_posi_5264': {'bp': 820016.0, 'sum': 1310338.0}, '11_posi_5120': {'bp': 1000818.0, 'sum': 1796420.0}, '3_posi_5226': {'bp': 871679.0, 'sum': 1503905.0}, '8_posi_5310': {'bp': 1014381.0, 'sum': 1938169.0}, '10_posi_5144': {'bp': 1029545.0, 'sum': 1718064.0}, '9_posi_5114': {'bp': 1026703.0, 'sum': 1819619.0}, '6_posi_5160': {'bp': 965586.0, 'sum': 1573836.0}, '8_posi_5225': {'bp': 944732.0, 'sum': 1588459.0}, '15_posi_5285': {'bp': 907420.0, 'sum': 1510647.0}, '4_posi_5136': {'bp': 1052139.0, 'sum': 1786456.0}, '2_posi_5162': {'bp': 1033984.0, 'sum': 1732390.0}, '4_posi_5220': {'bp': 975826.0, 'sum': 1598794.0}, '7_posi_5140': {'bp': 966058.0, 'sum': 1804339.0}, '10_posi_5245': {'bp': 952987.0, 'sum': 1536133.0}, '2_posi_5245': {'bp': 934100.0, 'sum': 1627722.0}, '17_posi_5204': {'bp': 911202.0, 'sum': 1525664.0}, '6_posi_5245': {'bp': 899075.0, 'sum': 1525816.0}, '5_posi_5222': {'bp': 892633.0, 'sum': 1460267.0}, '19_posi_5268': {'bp': 863112.0, 'sum': 1460450.0}, '5_posi_5059': {'bp': 1025503.0, 'sum': 1839010.0}, '12_posi_5179': {'bp': 1015483.0, 'sum': 1805999.0}, '14_posi_5102': {'bp': 910848.0, 'sum': 1725038.0}, '19_posi_5186': {'bp': 998191.0, 'sum': 1643673.0}, '7_posi_5226': {'bp': 927669.0, 'sum': 1682479.0}, '14_posi_5261': {'bp': 861698.0, 'sum': 1378741.0}, '12_posi_5096': {'bp': 1069692.0, 'sum': 2092332.0}, '15_posi_5204': {'bp': 842468.0, 'sum': 1463601.0}, '9_posi_5179': {'bp': 981719.0, 'sum': 1633662.0}, '14_posi_5182': {'bp': 964150.0, 'sum': 1539495.0}, '8_posi_5142': {'bp': 1028519.0, 'sum': 1741935.0}, '18_posi_5226': {'bp': 1026863.0, 'sum': 1758491.0}, '5_posi_5141': {'bp': 979034.0, 'sum': 1591248.0}}
COMMENT: RETENTION_TIME_STDEV 0.221
COMMENT: PRECURSOR_M/Z_RAW 212.139114
COMMENT: PRECURSOR_M/Z_STDEV 0.000066
COMMENT: PRECURSOR_IN_MS1 mz 212.139477; int 140.421; delta(ppm) 1.044989
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.606; C10H17N3O2; [M+H]+; delta(ppm) 0.606255
COMMENT: PROPOSED_MF MS-FINDER 3.389; C10H17N3O2; [M+H]+; delta(ppm) 0.602244
COMMENT: PROPOSED_MF SIRIUS5_Sirius 4.822; C10H17N3O2; [M+H]+; delta(ppm) 0.602244
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H17N3O2; [M+H]+; delta(ppm) 0.602244
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.211; C10H17N3O2; [M+H]+; delta(ppm) 0.602244
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.098; C12H19O3; [M+H]+; delta(ppm) -5.726879
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.792; C6H20N4O2P; [M+H]+; delta(ppm) -0.854831
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.480; C5H19N6OS; [M+H]+; delta(ppm) -8.959612
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.320; C8H15N6O; [M+H]+; delta(ppm) 6.931446
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.610; C3H17N9S; [M+H]+; delta(ppm) -2.630530
COMMENT: PROPOSED_MF SIRIUS6_Sirius -6.046; C4H18N7OP; [M+H]+; delta(ppm) 5.474353
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H17N3O2; [M+H]+; delta(ppm) 0.602244
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.533; JLLJHQLUZAKJFH-UHFFFAOYSA-N; [M+H]+; CN(C)C(=O)NC1=NOC(=C1)C(C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.500; LDVAGCGRLQBHOA-YZYOREDDNA-N; [M+H]+; CNCC[C@@H]1NC(=O)[C@@H]2CCCN2C1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.467; ZSHFTPZYVBOBQN-UHFFFAOYSA-N; [M+H]+; OC1CN(C)C(C2=NC(=NO2)C(C)C)C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.458; RXMDGBPKUGONKK-UHFFFAOYSA-N; [M+H]+; O=C1N=C(NC)C(C(=O)N1C)(CC)CC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.451; QLKBWHMZCWBCBD-UHFFFAOYSA-N; [M+H]+; O=C1N=C(N)C(C(=O)N1)(CC)C(C)CC
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.410; LDVAGCGRLQBHOA-YZYOREDDNA-N; [M+H]+; UNPD109990
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.306; RXMDGBPKUGONKK-UHFFFAOYSA-N; [M+H]+; 5,5-diethyl-3-methyl-6-(methylamino)-2,3,4,5-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.302; BTXRRFKBIDONGD-UHFFFAOYSA-N; [M+H]+; CNP0428779
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.302; HQKKVUATDCAHCN-UHFFFAOYSA-N; [M+H]+; CNP0433622
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.302; NUIRMULPGYHCPS-UHFFFAOYSA-N; [M+H]+; 5,5-diethyl-6-imino-1,3-dimethyl-1,3-diazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.302; QLKBWHMZCWBCBD-UHFFFAOYSA-N; [M+H]+; 6-amino-5-(butan-2-yl)-5-ethyl-2,3,4,5-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.302; SQIUPQMILOYKBN-UHFFFAOYSA-N; [M+H]+; CNP0444762
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.288; PWXSTLNPOMCOOD-UHFFFAOYSA-N; [M+H]+; CNP0441933
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.247; JLLJHQLUZAKJFH-UHFFFAOYSA-N; [M+H]+; Isouron
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.247; RNNBHZYEKNHLKT-UHFFFAOYSA-N; [M+H]+; Isolan
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.247; IGHRRSYNMNYEPY-UHFFFAOYSA-N; [M+H]+; 1-[3-(propylamino)propyl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.247; ZSHFTPZYVBOBQN-UHFFFAOYSA-N; [M+H]+; CNP0451017
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BTXRRFKBIDONGD-UHFFFAOYSA-N; [M+H]+; CNP0428779
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.717; HQKKVUATDCAHCN-UHFFFAOYSA-N; [M+H]+; CNP0433622
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.717; QLKBWHMZCWBCBD-UHFFFAOYSA-N; [M+H]+; 6-amino-5-(butan-2-yl)-5-ethyl-2,3,4,5-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.717; SQIUPQMILOYKBN-UHFFFAOYSA-N; [M+H]+; CNP0444762
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JLLJHQLUZAKJFH-UHFFFAOYSA-N; [M+H]+; Isouron
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RNNBHZYEKNHLKT-UHFFFAOYSA-N; [M+H]+; Isolan
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LDVAGCGRLQBHOA-YZYOREDDNA-N; [M+H]+; UNPD109990
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IGHRRSYNMNYEPY-UHFFFAOYSA-N; [M+H]+; 1-[3-(propylamino)propyl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NUIRMULPGYHCPS-UHFFFAOYSA-N; [M+H]+; 5,5-diethyl-6-imino-1,3-dimethyl-1,3-diazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; PWXSTLNPOMCOOD-UHFFFAOYSA-N; [M+H]+; CNP0441933
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RXMDGBPKUGONKK-UHFFFAOYSA-N; [M+H]+; 5,5-diethyl-3-methyl-6-(methylamino)-2,3,4,5-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZSHFTPZYVBOBQN-UHFFFAOYSA-N; [M+H]+; CNP0451017
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.797; RNNBHZYEKNHLKT-UHFFFAOYSA-N; [M+H]+; (5-methyl-2-propan-2-ylpyrazol-3-yl) N,N-dimethylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.375; JLLJHQLUZAKJFH-UHFFFAOYSA-N; [M+H]+; 3-(5-tert-butyl-1,2-oxazol-3-yl)-1,1-dimethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.131; WWYIZMBRAYKRFU-UHFFFAOYSA-N; [M+H]+; 6-amino-1,3-dipropylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; LGFDUQREKBPBSF-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)-3-(3-propan-2-ylimidazol-4-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; LPIJERWHZYVVLP-UHFFFAOYSA-N; [M+H]+; 4-(tert-butyldiazenyl)-4-cyanopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.105; DJFSJKPXNYYPFK-UHFFFAOYSA-N; [M+H]+; ethyl 5-amino-1-tert-butylpyrazole-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.911; SAIIUEANDOBPEJ-UHFFFAOYSA-N; [M+H]+; N-[1-(dimethylamino)ethylidene]-2-(2-oxopyrrolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.892; KBYIGOZJUBSJGO-UHFFFAOYSA-N; [M+H]+; 1-[(4-methylpiperazin-1-yl)methyl]pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; VNHALUREALLPEZ-UHFFFAOYSA-N; [M+H]+; 3-(azepan-2-yl)-5-(methoxymethyl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.756; PNQZHWFCGULKMU-UHFFFAOYSA-N; [M+H]+; [1-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-4-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.453; BMUGRYHDPWZUMF-ZJUUUORDSA-N; [M+H]+; (2S,3R)-2-[1-(2-methoxyethyl)pyrazol-4-yl]oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.450; GDPSCFYDXPEIEE-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-cyanopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.449; CBFXRUGJRMBDFG-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-cyanopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.444; NFLVTBMZGLRSPT-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-amino-3-cyanopyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.443; HTFUSRKVFAHZAU-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-amino-4-cyanopyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.443; YCIUFWZZINYMBA-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-cyanopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.443; UGUOPGYXDOYPNK-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(4-aminopyrazol-1-yl)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.442; OZLVHKOTGJTGKW-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-amino-2-(2-methylpyrazol-3-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.442; MNZBPGHOGCTODW-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(aminomethyl)-3-cyanoazetidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.442; BLTQSRWYTFSLNO-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-(aminomethyl)-3-methylimidazole-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.128; AZYDWKHQWJEWGN-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[2-(1H-imidazol-5-yl)ethyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.128; WAKMYFWZEZJYGK-UHFFFAOYSA-N; [M+H]+; tert-butyl N-(1,2-dimethylimidazol-4-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; AGKJIKWXTBMMBO-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[2-(1H-pyrazol-5-yl)ethyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; HSRKXSSNMPSEKO-UHFFFAOYSA-N; [M+H]+; 2-(diethylamino)-N-(3-methyl-1,2-oxazol-5-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; CPIGAJAJPFSXGZ-UHFFFAOYSA-N; [M+H]+; 5-methyl-N'-pentyl-1,2-oxazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; MMXVHUNQNUFIDW-UHFFFAOYSA-N; [M+H]+; 3-(3-aminopropyl)-1,3-diazaspiro[4.4]nonane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; ATDDJQBFBPEELU-UHFFFAOYSA-N; [M+H]+; 5-ethyl-3-(piperidin-4-yloxymethyl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; PAGQXFSRGPLPCD-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[1-(1H-pyrazol-4-yl)ethyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; NUNLJNOCEIDSLP-UHFFFAOYSA-N; [M+H]+; 3-[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.548; AZYDWKHQWJEWGN; [M+H]+; Histamine, N-t-butyloxycarbonyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.345; GDPSCFYDXPEIEE; [M+H]+; tert-butyl 4-cyanopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.678; HTFUSRKVFAHZAU; [M+H]+; tert-butyl 3-amino-4-cyanopyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.504; SAIIUEANDOBPEJ; [M+H]+; N,N-Dimethyl-N''-(pyrrolidon-2-yl-1-acetyl)acetamidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -295.613; OZLVHKOTGJTGKW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -297.147; RNNBHZYEKNHLKT; [M+H]+; Isolane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -314.233; KBYIGOZJUBSJGO; [M+H]+; N-(4-Methyl-1-piperazinylmethyl)succinimide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.488; WWYIZMBRAYKRFU; [M+H]+; 6-Amino-1,3-dipropyluracil
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -332.397; IGHRRSYNMNYEPY; [M+H]+; 1-[3-(propylamino)propyl]pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -339.934; LDVAGCGRLQBHOA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -341.497; JLLJHQLUZAKJFH; [M+H]+; Caswell No. 419E
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -341.810; JIIACZGGPNZBCU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -373.392; ZSHFTPZYVBOBQN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -376.859; GOOFEMZNDQPZOU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -396.869; HSRKXSSNMPSEKO; [M+H]+; 5-(2-(Diethylamino)acetamido)-3-methylisoxazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -404.677; SQIUPQMILOYKBN; [M+H]+; Ambcb5122613
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -405.465; HQKKVUATDCAHCN; [M+H]+; Ambcb5122611
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -406.912; BTXRRFKBIDONGD; [M+H]+; 5-ethyl-6-imino-1-methyl-5-propyl-1,3-diazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -411.774; PWXSTLNPOMCOOD; [M+H]+; 5,5-diethyl-1-methyl-2-(methylamino)pyrimidine-4,6-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -428.638; QLKBWHMZCWBCBD; [M+H]+; 6-amino-5-butan-2-yl-5-ethylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -436.744; RXMDGBPKUGONKK; [M+H]+; 5,5-diethyl-3-methyl-6-(methylamino)pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -438.377; NUIRMULPGYHCPS; [M+H]+; 2,4(1H,3H)-Pyrimidinedione, 5,5-diethyldihydro-6-imino-1,3-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.543; AZYDWKHQWJEWGN; [M+H]+; Histamine, N-t-butyloxycarbonyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -161.008; AZYDWKHQWJEWGN; [M+H]+; tert-butyl N-[2-(1H-imidazol-5-yl)ethyl]carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.976; UGUOPGYXDOYPNK; [M+H]+; tert-butyl 3-(4-amino-1H-pyrazol-1-yl)propanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -221.711; OZLVHKOTGJTGKW; [M+H]+; tert-butyl 2-amino-2-(1-methyl-1H-pyrazol-5-yl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -226.867; GDPSCFYDXPEIEE; [M+H]+; Tert-butyl 4-cyanopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -236.566; RNNBHZYEKNHLKT; [M+H]+; Isolan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -244.389; DJFSJKPXNYYPFK; [M+H]+; ethyl 5-amino-1-tert-butyl-1H-pyrazole-4-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -256.437; CBFXRUGJRMBDFG; [M+H]+; (R)-tert-Butyl 3-cyanopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -258.184; RGIIKOKBGRWBCV; [M+H]+; N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -264.916; HTFUSRKVFAHZAU; [M+H]+; tert-butyl (3S,4S)-3-amino-4-cyanopyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -281.172; ATDDJQBFBPEELU; [M+H]+; 4-[(5-Ethyl-1,2,4-oxadiazol-3-yl)methoxy]piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.365; AZYDWKHQWJEWGN; [M+H]+; tert-butyl N-[2-(1H-imidazol-5-yl)ethyl]carbamate
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C10H18N3O2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 10.383
MS$FOCUSED_ION: PRECURSOR_M/Z 212.139481
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-0090000000-11cdaa426ff9d11fcdc1
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  86.0599733 7.0640 86.060440 1.3363 1.75 0.0779 45 f{C4H8N1O1}/-0.78ppm,p-C6H10N2O1
  125.0948189 8.2755 125.094860 1.9505 1.72 0.4011 45 f{C6H11N3}/0.56ppm,p-C4H7O2
  126.1024332 16.4269 126.102460 1.6177 2.64 0.6031 47 f{C6H12N3}/-1.12ppm,p-C4H6O2
  152.1181435 6.6894 152.118040 2.3929 1.61 -0.1697 37 f{C8H14N3}/-0.53ppm,p-C2H4O2
  195.1603809 7.4001 195.160250 2.1162 2.16 -0.0644 39 ?
  212.1393214 999.0000 212.139180 0.3488 0.00 1.0000 47 f{C10H18N3O2}/-0.15ppm,p
  212.1865314 610.8741 212.186390 0.3912 98.20 0.6151 47 ?
PK$NUM_PEAK: 7
PK$PEAK: m/z int. rel.int.
  86.059973 7.06 7
  125.094819 8.28 8
  126.102433 16.43 16
  152.118144 6.69 6
  195.160381 7.40 7
  212.139321 999.00 999
  212.186531 610.87 610
//
